Fraud
Celularity Faces Nasdaq Delisting Risk Over Delayed Financial Filings
Regenerative medicine company Celularity received notification from Nasdaq that it is non-compliant with listing rules after failing to file quarterly reports for periods ending March 31 and June 30, 2026....
Trinity Place Holdings Reports Q2 Loss as IP Monetization Strategy Continues
The intellectual property holding company reported a net loss of $298,000 for the first half of 2026 while managing $329.9 million in federal net operating loss carryforwards from its predecessor, bankrupt retailer Syms Corp....